DS
CELZ icon

DRW Securities’s Creative Medical Technology CELZ Stock Holding History

DRW Securities’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,319
Closed -$20.2K – 1341
2025
Q4 		$20.2K Sell
10,319
-4,782
-32% -$14.1K ﹤0.01% 1167
2025
Q3 		$50.3K Buy
+15,101
New +$46.8K ﹤0.01% 1229

Other funds holding CELZ

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

DRW Securities's CELZ Position: Q1 2026 in Review

DRW Securities sold out of Creative Medical Technology (CELZ) in Q1 2026, closing a stake of 10,319 shares — an estimated $20.2K sold.

DRW Securities first reported a position in CELZ in Q3 2025 and held it in 2 quarters. The position peaked at $50.3K in Q3 2025. 11 funds tracked by Wall St. Rank hold CELZ as of Q1 2026.

  • DRW Securities reported no remaining Creative Medical Technology position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 10,319 Creative Medical Technology shares in Q1 2026, an estimated $20.2K.
  • DRW Securities first reported a position in Creative Medical Technology in Q3 2025 and held it in 2 quarters.
  • DRW Securities's Creative Medical Technology position peaked at $50.3K in Q3 2025.
  • 11 funds tracked by Wall St. Rank held Creative Medical Technology as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.